Syneos Health, a fully integrated biopharmaceutical solutions company, agreed to acquire Kinapse, an advisory and operational solutions provider to the global life sciences industry. Financial terms were not disclosed. “As customers increasingly face risk, competition and rising development costs, the innovative, technology-enabled solutions provided by Kinapse are seeing increasing demand. Through this combination we continue to inject new and enriched high-value solutions into the industry’s only end-to-end offering, unlocking value for all of our biopharmaceutical customers. Additionally, with Kinapse’s growth, recurring revenue streams and new cross-selling opportunities, we’re poised to further strengthen our Commercial business by integrating their services into more comprehensive offerings,” Alistair Macdonald, Syneos Health CEO.